隐源性肝硬化与NASH肝硬化是否不同?
基于UNOS数据库2002-2016年数据,比较隐源性肝硬化(CC,n=7999)与NASH肝硬化(n=11302)、酒精性肝硬化(n=21714)及自身免疫性肝炎肝硬化(n=3447)的临床特征。NASH组2型糖尿病(53%)、肥胖(65.3%)及肝细胞癌(19%)比例均高于CC组(分别为29%、33-42%区间、9-13%),按年龄、性别及登记年份匹配后差异仍不变。作者认为从风险角度看,CC不应等同于NASH肝硬化。
要点
- 2002至2016年,以NASH为诊断登记的患者比例从约1%升至16%,而CC从8%降至4%。
- NASH组2型糖尿病53%、肥胖65.3%,均高于CC组(29%、33-42%)。
- 肝细胞癌在NASH组为19%,高于其他三组的9-13%,且不受肥胖和2型糖尿病影响。
核心结论
- 基于风险角度,隐源性肝硬化不应等同于NASH肝硬化。
- 需要进一步研究以识别肝硬化的未知病因。
研究设计与样本
- 利用UNOS数据库2002-2016年数据,比较成人CC(n=7999)与NASH肝硬化(n=11302)、酒精性肝硬化(n=21714)及自身免疫性肝炎肝硬化(n=3447)的临床特征。
- 对CC与NASH按年龄、性别及登记年份进行匹配比较(每组n=7201),并按是否肥胖或2型糖尿病进行分层。
- 使用整个UNOS数据(n=138021)建立逻辑回归模型分析NASH的预测因素。
主要发现
- 2002至2016年,以NASH为诊断登记的患者从约1%增至16%,CC从8%降至4%。
- 逻辑回归模型提示NASH最强的预测因素为2型糖尿病、肥胖、年龄≥60岁、女性及白人种族。
- 2型糖尿病在NASH组为53%,高于CC组29%、酒精性肝硬化组16%及自身免疫性肝炎组16%。
- 肥胖在NASH组为65.3%,高于其他三组的33-42%。
- 肝细胞癌在NASH组为19%,高于其他三组的9-13%,且不受肥胖和2型糖尿病影响。
关键数值与推荐
- NASH组白人占82.3%,黑人、西班牙裔及亚裔比例低于其他三组。
- CC与NASH的差异在按年龄、性别及登记年份匹配后,或按是否肥胖或2型糖尿病分层后,仍保持不变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究以识别肝硬化的未知病因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We hypothesized that patients currently diagnosed with cryptogenic cirrhosis (CC) have truly 'cryptogenic' liver disease, which is unlikely to have evolved from NASH. The aim of this study is to characterize patients with CC, and compare their characteristics to patients with cirrhosis of other etiologies. METHODS: To investigate this, we compared the clinical characteristics of adults with CC (n = 7,999) to those with cirrhosis caused by non-alcoholic steatohepatitis (NASH) (n = 11,302), alcohol (n = 21,714) and autoimmune hepatitis (n = 3,447), using the UNOS database from 2002-16. We performed an age, gender and year of listing matched comparison of CC and NASH (n = 7,201 in each group), and also stratified patients by the presence of obesity or diabetes mellitus (DM). RESULTS: From 2002 to 2016, patients listed with a diagnosis of NASH increased from about 1% to 16% while CC decreased from 8% to 4%. A logistic regression model using the entire United Network for Organ Sharing data (n = 138,021) suggested that the strongest predictors of NASH were type 2 DM, obesity, age ≥60 years, female gender and white race. Type 2 DM was more common in patients with NASH (53%) than those with CC (29%), alcoholic cirrhosis (16%) and autoimmune hepatitis (16%), and obesity was more common in NASH (65.3%) compared to the other three groups (33-42%). There were more white individuals (82.3%) in the NASH group and a lower prevalence of black, Hispanic and Asian individuals, compared to the other three groups. Hepatocellular carcinoma was more commonly seen in NASH (19% vs. 9-13% in the other groups) and this is not influenced by obesity and type 2 DM. The differences between CC and NASH remained unchanged even when two groups were matched for age, gender and year of listing, or when stratified by the presence or absence of obesity or type 2DM. CONCLUSIONS: Based on risk perspectives, CC should not be equated with the term 'NASH cirrhosis'. LAY SUMMARY: We hypothesized that cryptogenic cirrhosis is a distinct condition from cirrhosis caused by non-alcoholic steatohepatitis (NASH). By comparing cryptogenic cirrhosis with cirrhosis of other causes, we found clear clinical differences. Therefore, cryptogenic cirrhosis should not be considered the same as NASH cirrhosis. Further investigations are required to identify unknown causes of cirrhosis.
引用
- Thuluvath PJ, Kantsevoy S, Thuluvath AJ, et al. Is cryptogenic cirrhosis different from NASH cirrhosis? J Hepatol. 2017. PMID: 29162389. doi:10.1016/j.jhep.2017.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。